A case of acute neuropathy caused by rapid glycemic control with insulin in a diabetic patient which was treated with lumbar sympathetic blocks

Background: Management of diabetes remains a challenge in Africa. Objective: The aim of this study was to evaluate the glycemic control in diabetics patients with diabetes in Gabon sub-Saharan country. Methods: This study involving 87 diabetic patients (Men25 ; Women : 62) were investigated anthropometric parametres, glycemic control and biochemical profil. Results: All our results show that with an average age of 53±11.02 years diabetic Gabonese patients present a poor glycemic control (P <0.0001): Glycemia (Control: 4.95 ± 1.16 mmol/l vs Diabetic : 10.27 ± 4.47 mmol/l) ; HbA1c (Control : 5.05 ± 0.46% vs Diabetics : 7.40 ± 2.36%) associated with a hepatic steatosis : Alat ( Alat : Control: 17.25 ± 13.7u/l vs Diabetic: 25.84 ± 13.19 u/l), Asat (Control: 18 ± 13.20 u/l vs Diabetic: 36.93 ± 17.87 u/l). Conclusion: Is evidence, a high proportion of patients with diabetes remains poorly controlled. This is the case in Gabon diabetic patients.

Download Full-text

Complicated plantar ulcer in diabetic patient with multiple comorbidities

ABOUTOPEN ◽

10.19156/abtpn.2018.0049 ◽

2018 ◽

Vol 4 (1) ◽

pp. 86-88

Author(s):

Luca Monge

Keyword(s):

Diabetes Mellitus ◽

Cardiovascular Disease ◽

High Risk ◽

Glycemic Control ◽

Diabetic Patient ◽

Diabetic Foot ◽

Good Glycemic Control ◽

Plantar Ulcer ◽

Severe Renal Insufficiency ◽

Frequent Presence

Diabetic foot syndrome is characterized by an intrinsic patient fragility and involves complex medical and surgical therapeutic approach. Lesions, often chronic, have a high risk of recurrence and amputation. The patient with diabetic foot is more frequently affected by comorbidities, not only for micro-angiopathic complications of diabetes mellitus but also for the frequent presence of cardiovascular disease. We report the case of a 63-year-old diabetic patient with multiple comorbidities. Treatment with linagliptin allowed to simplify the therapy for glycemic control, switching from a injective therapy four times daily to a therapy with only basal insulin and linagliptin. This therapy has proven to be safe and suitable to maintain good glycemic control even in a fragile patient with diabetic foot and middle-severe renal insufficiency of diabetic origin (Diabetology).

Download Full-text

Insulin Sensitivity and Glycemic Control Before and After Parathyroidectomy in a Diabetic Patient with Familial Multiple Endocrine Neoplasia Type 1.

Endocrine Journal ◽

10.1507/endocrj.41.731 ◽

1994 ◽

Vol 41 (6) ◽

pp. 731-735 ◽

Cited By ~ 3

Author(s):

SUMIKO FURUTO-KATO ◽

AKIRA SHIMATSU ◽

HIDESHI KUZUYA ◽

KIMISHT MATSUDA ◽

KAZUWA NAKAO ◽

...

Keyword(s):

Insulin Sensitivity ◽

Glycemic Control ◽

Diabetic Patient ◽

Multiple Endocrine Neoplasia ◽

Multiple Endocrine Neoplasia Type ◽

Endocrine Neoplasia ◽

Endocrine Neoplasia Type ◽

Before And After

Download Full-text

Unstable glycemic control in a type 2 diabetic patient with anti-insulin antibody was improved by plasma exchange.

Nihon Naika Gakkai Zasshi ◽

10.2169/naika.94.2182 ◽

2005 ◽

Vol 94 (10) ◽

pp. 2182-2185

Author(s):

Chisa Nakagawa ◽

Etsuko Takeda ◽

Hideki Ohno ◽

Masaharu Kubo ◽

Yoshiharu Nishida ◽

...

Keyword(s):

Glycemic Control ◽

Diabetic Patient ◽

Plasma Exchange ◽

Insulin Antibody ◽

Type 2 Diabetic

Download Full-text

The Difference of Brainstem Auditory Evoked Potential Latency in Diabetic Patient with Good and Poor Glycemic Control

Open Access Macedonian Journal of Medical Sciences ◽

10.3889/oamjms.2020.3403 ◽

2020 ◽

Vol 8 (B) ◽

pp. 457-462

Author(s):

D. P. G. Purwa Samatra ◽

Grace Meliana ◽

I. G. N. Purna Putra ◽

I Putu Eka Widyadharma

Keyword(s):

Nervous System ◽

Glycemic Control ◽

Diabetic Patient ◽

Evoked Potential ◽

Smoking Habit ◽

Auditory Evoked Potential ◽

Poor Glycemic Control ◽

Control Group ◽

Cross Sectional ◽

Brainstem Auditory Evoked Potential

BACKGROUND: Diabetes mellitus (DM) is a metabolic disorder which may complicate other organs, including the nervous system. Literatures which discuss about DM complications in the peripheral nervous system are easy to find but not so many of the central nervous system. Central diabetic neuropathy is a new concept which could be detected by a simple and non-invasive method, called brainstem auditory evoked potential (BAEP). AIM: The aim of the study was to find differences in BAEP latencies of a diabetic patient with good and poor glycemic control. METHODS: This was a cross-sectional study of 80 patients who came for follow-up in diabetic center and neurology polyclinic at Sanglah Hospital, from April to July 2016. The subjects were divided into two groups, depending on their glycemic control, then having BAEP examination. RESULTS: The unpaired t-test found prolonged BAEP latencies (either peak latency of wave III, V, IPL I-III, III-V, and I-V) in both ears at the poor glycemic control group, but the results were not differed significantly (p > 0.05). CONCLUSION: BAEP wave latencies were found prolonged in DM patient with poor glycemic control but not statistically significant. Further evaluation of BAEP latencies in DM patients is needed with prolonged duration and their relation with other comorbid factors, especially smoking habit.

Download Full-text